• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺癌垂体转移。

Pituitary metastasis of thyroid cancer.

机构信息

Section of Endocrinology, ASL6, Viale Alfieri 36, Livorno, Italy.

出版信息

Endocrine. 2013 Jun;43(3):485-93. doi: 10.1007/s12020-012-9806-9. Epub 2012 Sep 26.

DOI:10.1007/s12020-012-9806-9
PMID:23008095
Abstract

Pituitary metastases (PM) from thyroid cancer are rare, but their management can represent a difficult challenge for the endocrinologist. Our aim was to review all reported cases of PM from thyroid cancer. PubMed was consulted and 19 papers reporting 20 cases were found. We moreover discuss two of our own cases, which had come to our attention within a few months of one another. Eleven cases were follicular cancer, eight cases were papillary cancer, two cases were medullary cancer, and one case was an insular cancer. In nine cases, PM was the first sign of the disease. Cranial nerve involvement was the most common sign of its presence, and no neuroradiological imaging could lead to a sure diagnosis of PM. Neurosurgical intervention was performed in almost all cases, and post-surgical treatment comprised radioiodine, external beam radiotherapy, and radiosurgery. Prognosis was poor for larger metastases, cranial nerve palsy disappeared in only one case, and in only one case of intrasellar metastasis was the disease cured. PM from thyroid cancer are rare, but are burdened by a poor prognosis. An early diagnosis appears important, and a comprehensive strategy for treatment (neurosurgery, radioiodine, external radiotherapy, and radiosurgery) appears advisable.

摘要

垂体转移瘤(PM)来自甲状腺癌较为罕见,但对内分泌学家而言,其管理可能极具挑战性。我们旨在回顾所有报道的甲状腺癌 PM 病例。查阅了 PubMed,并发现了 19 篇报告 20 例病例的论文。此外,我们还讨论了我们自己的两个病例,这两个病例在彼此相隔数月的时间里引起了我们的注意。11 例为滤泡癌,8 例为乳头状癌,2 例为髓样癌,1 例为胰岛细胞癌。9 例 PM 是疾病的首发表现。颅神经受累是其存在的最常见征象,且无神经影像学检查可明确诊断 PM。几乎所有病例均进行了神经外科干预,术后治疗包括放射性碘、外照射放疗和放射外科治疗。对于较大的转移灶,预后较差,仅 1 例颅神经麻痹消失,仅 1 例鞍内转移病例治愈。甲状腺癌 PM 较为罕见,但预后较差。早期诊断似乎很重要,全面的治疗策略(神经外科、放射性碘、外照射放疗和放射外科治疗)似乎是合理的。

相似文献

1
Pituitary metastasis of thyroid cancer.甲状腺癌垂体转移。
Endocrine. 2013 Jun;43(3):485-93. doi: 10.1007/s12020-012-9806-9. Epub 2012 Sep 26.
2
Pituitary metastasis from medullary carcinoma of thyroid: case report and review of literature.甲状腺髓样癌的垂体转移:病例报告及文献复习
J Neurooncol. 2008 Aug;89(1):63-7. doi: 10.1007/s11060-008-9586-5. Epub 2008 Apr 12.
3
Outcomes and prognostic factors in thyroid cancer patients with cranial metastases: A retrospective cohort study of 4,683 patients.甲状腺癌颅转移患者的预后和影响因素:4683 例患者的回顾性队列研究。
Int J Surg. 2018 Jul;55:182-187. doi: 10.1016/j.ijsu.2018.06.001. Epub 2018 Jun 5.
4
Divergent Metastatic Patterns Between Subtypes of Thyroid Carcinoma Results From the Nationwide Dutch Pathology Registry.甲状腺癌亚型之间转移模式的差异源于全国荷兰病理登记处。
J Clin Endocrinol Metab. 2020 Mar 1;105(3):e299-306. doi: 10.1210/clinem/dgz078.
5
Management of brain metastases from thyroid carcinoma: a study of 16 pathologically confirmed cases over 25 years.甲状腺癌脑转移的治疗:25年间16例病理确诊病例的研究
Cancer. 2003 Jul 15;98(2):356-62. doi: 10.1002/cncr.11488.
6
Pituitary metastasis of follicular thyroid carcinoma.滤泡状甲状腺癌的垂体转移
Horm Res. 2004;61(4):190-2. doi: 10.1159/000076387. Epub 2004 Jan 25.
7
Medullary thyroid carcinoma metastatic to the pituitary gland: an unusual site of metastasis.甲状腺髓样癌转移至垂体:一个不寻常的转移部位。
Ann Diagn Pathol. 2008 Jun;12(3):199-203. doi: 10.1016/j.anndiagpath.2006.08.007. Epub 2007 Aug 17.
8
Surgical treatment strategy for thyroid gland carcinoma nodal metastases.甲状腺癌淋巴结转移的手术治疗策略
Eur Arch Otorhinolaryngol. 1997;254 Suppl 1:S169-74. doi: 10.1007/BF02439753.
9
The impact of nodal metastases on prognosis of well-differentiated thyroid cancer suggests the practice of prophylactic neck dissection.淋巴结转移对高分化甲状腺癌预后的影响提示了预防性颈淋巴结清扫术的应用。
Arch Otolaryngol Head Neck Surg. 2003 Apr;129(4):495-6; author reply 496. doi: 10.1001/archotol.129.4.495-b.
10
Pituitary metastases from follicular thyroid carcinoma.甲状腺滤泡癌垂体转移。
Thyroid. 2010 Jul;20(7):823-30. doi: 10.1089/thy.2009.0256.

引用本文的文献

1
Distinguishing Pituitary Metastasis and Pituitary Neuroendocrine Tumors through Conventional MR Imaging and Clinical Features.通过常规磁共振成像和临床特征鉴别垂体转移瘤和垂体神经内分泌肿瘤。
AJNR Am J Neuroradiol. 2024 Aug 9;45(8):1063-1069. doi: 10.3174/ajnr.A8302.
2
Neuro-ophthalmological findings of pituitary metastasis: Case series from a single center and review of the literature.垂体转移瘤的神经眼科表现:单中心病例系列及文献综述
Heliyon. 2024 Feb 7;10(4):e26027. doi: 10.1016/j.heliyon.2024.e26027. eCollection 2024 Feb 29.
3
Metastatic diffuse follicular variant papillary thyroid cancer without cervical lymph node metastasis presenting with symptoms related to hypopituitarism.

本文引用的文献

1
Changing natural history of differentiated thyroid cancer.分化型甲状腺癌自然病程的改变。
Endocrine. 2012 Oct;42(2):229-30. doi: 10.1007/s12020-012-9727-7.
2
The tale of two tumours: an undiagnosed case of papillary thyroid carcinoma.两颗肿瘤的故事:一例未被诊断出的乳头状甲状腺癌病例。
BMJ Case Rep. 2011 Dec 20;2011:bcr0820114604. doi: 10.1136/bcr.08.2011.4604.
3
Update on the diagnosis and management of hypophysitis.垂体炎的诊断与治疗进展。
无颈部淋巴结转移的转移性弥漫滤泡状甲状腺癌,表现为与垂体功能减退相关的症状。
Einstein (Sao Paulo). 2023 Jul 21;21:eRC0229. doi: 10.31744/einstein_journal/2023RC0229. eCollection 2023.
4
Pituitary Metastases From Differentiated Thyroid Cancers: A Systematic Review.分化型甲状腺癌的垂体转移:一项系统综述
World J Oncol. 2023 Jun;14(3):165-173. doi: 10.14740/wjon1593. Epub 2023 Jun 11.
5
Papillary Thyroid Cancer With Pituitary Gland Metastasis: A Unique Encounter.甲状腺乳头状癌伴垂体转移:一次独特的病例
Cureus. 2023 Apr 27;15(4):e38210. doi: 10.7759/cureus.38210. eCollection 2023 Apr.
6
Efficacy of anlotinib combined with radioiodine to treat scalp metastasis of papillary thyroid cancer: A case report and review of literature.安罗替尼联合放射性碘治疗甲状腺乳头状癌头皮转移的疗效:一例病例报告及文献复习
World J Clin Cases. 2023 Apr 26;11(12):2839-2847. doi: 10.12998/wjcc.v11.i12.2839.
7
The Pituitary Tumors and Their Tumor-Specific Microenvironment.垂体肿瘤及其肿瘤特异性微环境。
Adv Exp Med Biol. 2020;1296:117-135. doi: 10.1007/978-3-030-59038-3_7.
8
Pituitary metastases of Hürthle cell carcinoma of the thyroid.甲状腺 Hurthle 细胞癌的垂体转移。
BMJ Case Rep. 2021 Jan 18;14(1):e239456. doi: 10.1136/bcr-2020-239456.
9
Thyroid carcinoma with atypical metastasis to the pituitary gland and unexpected postmortal diagnosis.甲状腺癌伴垂体非典型转移及意外的死后诊断。
Endocrinol Diabetes Metab Case Rep. 2020 Mar 13;2020. doi: 10.1530/EDM-19-0148.
10
Sellar surprises: a single-centre experience of unusual sellar masses.鞍区的意外发现:单中心关于不寻常鞍区肿物的经验
Endocr Connect. 2020 Feb;9(2):111-121. doi: 10.1530/EC-19-0497.
Curr Opin Endocrinol Diabetes Obes. 2012 Aug;19(4):314-21. doi: 10.1097/MED.0b013e32835430ed.
4
Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997-2010): data from the University Hospital "Maggiore della Carità" in Novara.分化型甲状腺癌(DTC)随时间变化的临床病理变化:来自诺瓦拉马焦雷大学医院(University Hospital "Maggiore della Carità")的数据。(1997-2010 年)
Endocrine. 2012 Oct;42(2):382-90. doi: 10.1007/s12020-012-9612-4.
5
Cancer statistics, 2012.癌症统计数据,2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
6
The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.BRAF(V600E) 突变与甲状腺乳头癌预后因素及不良临床结局的相关性:一项荟萃分析。
Cancer. 2012 Apr 1;118(7):1764-73. doi: 10.1002/cncr.26500. Epub 2011 Aug 31.
7
Follicular thyroid carcinoma with metastases to the pituitary causing pituitary insufficiency.滤泡性甲状腺癌伴向垂体转移导致垂体功能不全。
Thyroid. 2011 Aug;21(8):921-5. doi: 10.1089/thy.2010.0335. Epub 2011 May 19.
8
Apoplexy in sellar metastasis: a case report and review of literature.鞍区转移瘤中的卒中:一例病例报告并文献复习
Turk Neurosurg. 2011;21(2):230-4. doi: 10.5137/1019-5149.JTN.2716-09.1.
9
Diagnosis and management of pituitary adenomas.垂体腺瘤的诊断与治疗。
Curr Opin Oncol. 2011 Jan;23(1):53-60. doi: 10.1097/CCO.0b013e328341000f.
10
Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 cases.BRAF V600E 突变与小于 20 毫米的甲状腺乳头状癌侵袭性的相关性:1060 例分析。
J Clin Endocrinol Metab. 2010 Sep;95(9):4197-205. doi: 10.1210/jc.2010-0337. Epub 2010 Jul 14.